Thrombotic Risk Stratification of Coronary Aneurysms in Kawasaki Disease Patients: Morphology, Hemodynamics, and a New Combined Score
Kawasaki disease (KD) is the leading cause of acquired heart disease in children worldwide—and one of its most dangerous complications is coronary artery aneurysms (CAAs). These weakened, bulging blood vessels in the heart can form life-threatening blood clots (thrombosis), blocking blood flow to the heart and causing heart attacks or sudden death. For doctors, the challenge is knowing which KD patients with CAAs need aggressive anticoagulation therapy—and which do not. A 2022 study from researchers at Sichuan University and West China Hospital offers a promising solution: a combined risk score that uses both the shape (morphology) and blood flow (hemodynamics) of CAAs to predict thrombosis.
Why Thrombotic Risk Matters for Kawasaki Disease CAAs
KD causes fever, rash, and swelling in young children—and in up to 25% of untreated cases, inflammation damages the coronary arteries (the vessels that supply the heart). This damage can lead to CAAs—weakened areas that bulge like a balloon. While most CAAs shrink over time, some persist. These persistent CAAs are at high risk of thrombosis (blood clots), which can cut off oxygen to the heart.
The American Heart Association (AHA) emphasizes that accurate risk stratification is critical. Over-treating with anticoagulants (blood thinners) can cause bleeding; under-treating can lead to clots. Until now, doctors relied mostly on size (aneurysm diameter) to assess risk—but size alone isn’t enough.
How the Study Worked
The researchers analyzed 48 CAAs from 29 KD patients who had coronary CT angiography (CTA) at West China Hospital. They divided the CAAs into two groups:
- High-risk: 18 CAAs with thrombosis (confirmed by CTA).
- Low-risk: 30 CAAs without thrombosis.
Using SimVascular (an open-source tool for cardiovascular modeling), they built 3D models of each CAA from CTA images. They tested 35 parameters: 17 related to morphology (size, volume, shape) and 18 related to hemodynamics (blood flow forces, cell activation, and how long blood stays in the aneurysm).
Ethical notes: The study was approved by the West China Hospital Ethics Committee. Since it was retrospective (using past data), written consent wasn’t required.
Key Findings: Morphology, Hemodynamics, and the Combined Score
The team found three critical insights:
1. Morphology: Size Is Important—but Not Everything
Morphology refers to the aneurysm’s physical structure. The study found:
- Multidimensional parameters are better: Metrics like volume (how much space the aneurysm takes up) and undulation index (how uneven the wall is) were more accurate at predicting thrombosis than simple diameter.
- No single factor is enough: Aneurysm size alone couldn’t reliably distinguish high- from low-risk CAAs.
- Dmax is the top morphological factor: Aneurysms with a maximum diameter (Dmax) of 8.2mm or larger were far more likely to have thrombosis. This 8.2mm cutoff is a key threshold for doctors.
2. Hemodynamics: Blood Flow Tells a Deeper Story
Hemodynamics tracks how blood moves through the aneurysm. High-risk CAAs had:
- Low wall shear stress (WSS): Slow, stagnant flow (ideal for clot formation).
- High oscillatory shear index (OSI): Turbulent flow that damages the artery wall.
- Longer relative residence time (RRT): More time for blood cells to stick together and form clots.
Relative parameters (e.g., the percentage of the aneurysm wall with low WSS) were more useful than absolute values (e.g., the lowest WSS measurement). For example, high-risk CAAs had 2–3x more area with low WSS than low-risk CAAs.
3. The Combined Risk Score (CRS) Is Most Accurate
The team combined the top morphological (Dmax) and hemodynamic (TAWSS average, OSI average, ECAP average, A(RRT>4)%) parameters into three scores:
- MRS (Morphology Risk Score): Based only on Dmax (8.2mm cutoff).
- HRS (Hemodynamics Risk Score): Based on four hemodynamic factors.
- CRS (Combined Risk Score): Adds MRS and HRS together.
The CRS was the most accurate, with an area under the curve (AUC) of 0.941 (meaning it correctly identified high-risk CAAs 94% of the time). The cutoff: CRS > 2 means high risk for thrombosis.
What This Means for Patients and Doctors
The CRS helps doctors make more informed decisions about anticoagulation. For example:
- A patient with a CRS of 3 (high risk) might start blood thinners immediately.
- A patient with a CRS of 1 (low risk) might be monitored instead of medicated.
This personalized approach reduces the risk of over- or under-treatment—key for balancing clot prevention and bleeding risk.
Limitations and Next Steps
The study had two main limitations:
- Small sample size: The team tested 48 CAAs—they need larger, more diverse groups to validate the CRS.
- CFD model improvements: Current models treat blood as a “Newtonian fluid” (like water) and assume arteries are rigid. Real blood is thicker at low flow, and arteries stretch. Adding these features will make the data more accurate.
Next steps: Validate the CRS in larger cohorts, improve CFD models, and test how well the score predicts long-term outcomes (e.g., heart attacks).
Conclusion
This study is a major step forward for KD CAA care. The Combined Risk Score (CRS) is the first tool to use both morphology and hemodynamics to predict thrombosis—and it’s more accurate than either alone. While more research is needed, the CRS offers hope for personalized, effective treatment. For KD patients with CAAs, it could mean the difference between unnecessary medication and life-saving care.
The study was published in the Chinese Medical Journal in 2022 by Haoyao Cao, Tinghui Zheng, Da Li, Jing Liu, Zhan Liu, and Liqing Peng (affiliated with Sichuan University and West China Hospital). doi: 10.1097/CM9.0000000000001931
Was this helpful?
0 / 0